{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:26:31Z","timestamp":1770135991469,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Zhejiang Provincial Public Welfare Technology Application Research Project","award":["LGF19H160001"],"award-info":[{"award-number":["LGF19H160001"]}]},{"name":"Zhejiang Provincial Medicine and Health Science and Technology Project","award":["2018KY789"],"award-info":[{"award-number":["2018KY789"]}]},{"name":"Huzhou Science and Technology Plan","award":["2018GZ38"],"award-info":[{"award-number":["2018GZ38"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ygyno.2018.12.028","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T19:13:33Z","timestamp":1546974813000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical significance of genotyping for human papillomavirus (HPV) 16 18\/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women"],"prefix":"10.1016","volume":"153","author":[{"given":"Jiajian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1934-7218","authenticated-orcid":false,"given":"Pingya","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.12.028_bb0005","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/annonc\/mdt538","article-title":"Cervical cancer screening: on the way to a shift from cytology to full molecular screening","volume":"25","author":"Dijkstra","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0010","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2018.12.028_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/380079a0","article-title":"Telomerase activation by the E6 gene product of human papillomavirus type 16","volume":"380","author":"Klingelhutz","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2018.12.028_bb0025","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/ijc.25915","article-title":"Eurogin 2010 roadmap on cervical cancer prevention","volume":"128","author":"Franceschi","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.12.028_bb0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.12788\/jcso.0039","article-title":"Cobas HPV test for first-line screening for cervical cancer","volume":"12","author":"Abraham","year":"2014","journal-title":"J. Commun. Support. Oncol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0035","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JCM.01674-10","article-title":"Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with hybrid capture 2 and cytology","volume":"49","author":"Clad","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0040","first-page":"1411","article-title":"Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I","volume":"20","author":"Wu","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.12.028_bb0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajog.2012.12.003","article-title":"APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results","volume":"208","author":"Stoler","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0050","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/IGC.0b013e318280f3bc","article-title":"Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection","volume":"23","author":"Nieves","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2018.12.028_bb0055","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"Cuzick","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.12.028_bb0060","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1128\/JCM.01013-15","article-title":"Head-to-head comparison of the RNA-based Aptima human papillomavirus (HPV) assay and the DNA-based hybrid capture 2 HPV test in a routine screening population of women aged 30 to 60 years in Germany","volume":"53","author":"Iftner","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2018.12.028_bb0070","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0080","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12253-015-0029-2","article-title":"Clinical performance of APTIMA human papillomavirus (HPV) 16 18\/45 mRNA genotyping testing for the detection of cervical intraepithelial neoplasia 3 (CIN3) or cancer in a select group of Chinese women","volume":"22","author":"Guo","year":"2016","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncy.21521","article-title":"The pap test and Bethesda 2014","volume":"123","author":"Nayar","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0090","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1055\/s-0035-1558052","article-title":"Precancerous lesions of the cervix, vulva and vagina according to the 2014 WHO classification of tumors of the female genital tract","volume":"75","author":"Reich","year":"2015","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0095","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/sim.5587","article-title":"A weighted generalized score statistic for comparison of predictive values of diagnostic tests","volume":"32","author":"Kosinski","year":"2013","journal-title":"Stat. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2018.12.028_bb0100","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.jcv.2015.10.027","article-title":"A review of the clinical performance of the Aptima HPV assay","volume":"76","author":"Haedicke","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1309\/AJCPHVD7MIP3FYVV","article-title":"Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study","volume":"144","author":"Reid","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/0008-5472.CAN-07-2754","article-title":"Type-dependent integration frequency of human papillomavirus genomes in cervical lesions","volume":"68","author":"Vinokurova","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0120","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.12.028_bb0130","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.7150\/jca.25614","article-title":"Prevalence and distribution of HPV genotypes in 1387 women with cervical intraepithelial neoplasia 2\/3 in Shanxi Province, China","volume":"9","author":"Wang","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.ygyno.2018.12.028_bb0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1309\/AJCPLCD8TTOMLJTB","article-title":"Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study","volume":"143","author":"Castle","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcv.2015.04.004","article-title":"Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women","volume":"67","author":"Luttmer","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.bjc.6600974","article-title":"Benefit of cervical screening at different ages: evidence from the UK audit of screening histories","volume":"89","author":"Sasieni","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.12.028_bb0155","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0160","doi-asserted-by":"crossref","first-page":"c1804","DOI":"10.1136\/bmj.c1804","article-title":"Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme","volume":"340","author":"Anttila","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2018.12.028_bb0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ajog.2011.06.101","article-title":"Prior knowledge of HPV status improves detection of CIN2+ by cytology screening","volume":"205","author":"Benoy","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2007.07.049","article-title":"Risk assessment to guide the prevention of cervical cancer","volume":"197","author":"Castle","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.12.028_bb0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818315427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818315427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T19:04:52Z","timestamp":1552935892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818315427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0090825818315427"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.12.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of genotyping for human papillomavirus (HPV) 16 18\/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}